1,790
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER)

ORCID Icon, , &
Pages 978-983 | Received 22 Jan 2022, Accepted 04 Mar 2022, Published online: 16 Mar 2022

References

  • Howe CJ, Cole SR, Lau B, et al. Selection bias due to loss to follow up in cohort studies. Epidemiology. 2016;27:91–97.
  • Hagstrom H, Nasr P, Ekstedt M, et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol. 2017;67(6):1265–1273.
  • Poynard T, Mathurin P, Lai CL, PANFIBROSIS Group, et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol. 2003;38(3):257–265.
  • Brooke HL, Talbäck M, Hörnblad J, et al. The swedish cause of death register. Eur J Epidemiol. 2017;32(9):765–773.
  • Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–667.
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the swedish national inpatient register. BMC Public Health. 2011;11:450.
  • Bengtsson B, Askling J, Ludvigsson JF, et al. Validity of administrative codes associated with cirrhosis in Sweden. Scand J Gastroenterol . 2020;55(10):1205–1206.
  • Barlow L, Westergren K, Holmberg L, et al. The completeness of the swedish cancer register: a sample survey for year 1998. Acta Oncol. 2009;48(1):27–33.
  • Torner A, Stokkeland K, Svensson A, et al. The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence. Hepatology. 2017;65(3):885–892.
  • Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735.
  • Laugesen K, Ludvigsson JF, Schmidt M, et al. Nordic health Registry-Based research: a review of health care systems and key registries. Clin Epidemiol. 2021;13:533–554.
  • Ludvigsson JF, Svedberg P, Olén O, et al. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423–437.
  • Hagström H, Adams LA, Allen AM, et al. Administrative coding in electronic health care record-based research of NAFLD: an expert panel consensus statement. Hepatology. 2021;74(1):474–482.
  • Ludvigsson JF, Håberg SE, Knudsen GP, et al. Ethical aspects of registry-based research in the nordic countries. Clin Epidemiol. 2015;7:491–508.
  • Simon TG, Duberg AS, Aleman S, et al. Association of aspirin with hepatocellular carcinoma and Liver-Related mortality. N Engl J Med. 2020;382(11):1018–1028.
  • Björkström K, Widman L, Hagström H. Risk of hepatic and extrahepatic cancer in NAFLD: a population-based cohort study. Liver International. 2022. DOI:https://doi.org/10.1111/liv.15195